Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL

Author(s):  
William H. Parsons ◽  
Nicholas T. Rutland ◽  
Jennifer A. Crainic ◽  
Joaquin M. Cardozo ◽  
Alyssa S. Chow ◽  
...  
Keyword(s):  
2021 ◽  
pp. 100383
Author(s):  
Laine Lysyk ◽  
Raelynn Brassard ◽  
Elena Arutyunova ◽  
Verena Siebert ◽  
Zhenze Jiang ◽  
...  

2010 ◽  
Vol 11 (5) ◽  
pp. 412-426 ◽  
Author(s):  
Anthony E. Civitarese ◽  
Paul S. MacLean ◽  
Stacy Carling ◽  
Lyndal Kerr-Bayles ◽  
Ryan P. McMillan ◽  
...  

2002 ◽  
Vol 323 (5) ◽  
pp. 835-843 ◽  
Author(s):  
Karlheinz Esser ◽  
Baris Tursun ◽  
Martin Ingenhoven ◽  
Georg Michaelis ◽  
Elke Pratje

2021 ◽  
Author(s):  
Viorica Liebe Lastun ◽  
Matthew Freeman

In metazoans, the architecture of the endoplasmic reticulum (ER) differs between cell types, and undergoes major changes through the cell cycle and according to physiological needs. Although much is known about how the different ER morphologies are generated and maintained, especially the ER tubules, how context dependent changes in ER shape and distribution are regulated and the factors involved are less characterized. Here, we show that RHBDL4, an ER-resident rhomboid protease, modulates the shape and distribution of the ER, especially under conditions that require rapid changes in the ER sheet distribution, including ER stress. RHBDL4 interacts with CLIMP-63, a protein involved in ER sheet stabilisation, and with the cytoskeleton. Mice lacking RHBDL4 are sensitive to ER stress and develop liver steatosis, a phenotype associated with unresolved ER stress. Our data introduce a new physiological role of RHBDL4 and also imply that this function does not require its enzymatic activity.


2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Tsung-Lin Cheng ◽  
Chao-Han Lai ◽  
Shinn-Jong Jiang ◽  
Jui-Hsiang Hung ◽  
Shi-Kai Liu ◽  
...  

Anoikis resistance allows metastatic tumor cells to survive in a homeless environment. Activation of epithelial growth factor receptor (EGFR) signaling is one of the key mechanisms for metastatic tumor cells to resist anoikis, yet the regulation mechanisms of homeless-triggered EGFR activation in metastatic tumor cells remain unclear. Rhomboid-like-2 (RHBDL2), an evolutionally conserved intramembrane serine protease, can cleave the EGF ligand and thus trigger EGFR activation. Herein, we demonstrated that RHBDL2 overexpression in human epithelial cells resulted in promotion of cell proliferation, reduction of cell adhesion, and suppression of anoikis. During long-term suspension cultures, increased RHBDL2 was only detected in aggressive tumor cell lines. Treatment with the rhomboid protease inhibitor or RHBDL2 shRNA increased cleaved caspase 3, a marker of apoptosis. Finally, inhibition of EGFR activation increased the cleaved caspase 3 and attenuated the detachment-induced focal adhesion kinase phosphorylation. Taken together, these findings provide evidence for the first time that RHBDL2 is a critical molecule in anoikis resistance of malignant epithelial cells, possibly through the EGFR-mediated signaling. Our study demonstrates RHBDL2 as a new therapeutic target for cancer metastasis.


2012 ◽  
Vol 63 (10) ◽  
pp. 3559-3570 ◽  
Author(s):  
Elinor P. Thompson ◽  
Stefan G. Llewellyn Smith ◽  
Beverley J. Glover

2016 ◽  
Vol 473 (18) ◽  
pp. 2863-2880 ◽  
Author(s):  
Jia Jia Lim ◽  
Youngjin Lee ◽  
Tue Tu Ly ◽  
Jung Youn Kang ◽  
Jung-Gyu Lee ◽  
...  

RHBDL4 is an active rhomboid that specifically recognizes and cleaves atypical, positively charged transmembrane endoplasmic reticulum-associated degradation (ERAD) substrates. Interaction of valosin-containing protein (p97/VCP) and RHBDL4 is crucial to retrotranslocate polyubiquitinated substrates for ERAD pathway. Here, we report the first complex structure of VCP-binding motif (VBM) with p97 N-terminal domain (p97N) at 1.88 Å resolution. Consistent with p97 adaptor proteins including p47-ubiquitin regulatory X (UBX), gp78-VCP-interacting motif (VIM), OTU1-UBX-like element, and FAF1-UBX, RHBDL4 VBM also binds at the interface between the two lobes of p97N. Notably, the RF residues in VBM are involved in the interaction with p97N, showing a similar interaction pattern with that of FPR signature motif in the UBX domain, although the directionality is opposite. Comparison of VBM interaction with VIM of gp78, another α-helical motif that interacts with p97N, revealed that the helix direction is inversed. Nevertheless, the conserved arginine residues in both motifs participate in the majority of the interface via extensive hydrogen bonds and ionic interactions with p97N. We identified novel VBM-binding mode to p97N that involves a combination of two types of p97–cofactor specificities observed in the UBX and VIM interactions. This highlights the induced fit model of p97N interdomain cleft upon cofactor binding to form stable p97–cofactor complexes. Our mutational and biochemical analyses in defining the specific interaction between VBM and p97N have elucidated the importance of the highly conserved VBM, applicable to other VBM-containing proteins. We also showed that RHBDL4, ubiquitins, and p97 co-operate for efficient substrate dislocation.


2019 ◽  
Vol 141 (43) ◽  
pp. 17314-17321 ◽  
Author(s):  
Chaowei Shi ◽  
Carl Öster ◽  
Claudia Bohg ◽  
Longmei Li ◽  
Sascha Lange ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document